|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 35/50 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2203176 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08834753.9 |
| Date of filing the European patent application | 2008-09-29 | |
| (97) | Date of publication of the European application | 2010-07-07 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-26 |
| (46) | Date of publication of the claims translation | 2015-03-25 |
| (86) | Number | PCT/US2008/011251 |
| Date | 2008-09-29 |
| (87) | Number | WO 2009/045360 |
| Date | 2009-04-09 |
| (30) | Number | Date | Country code |
| 995763 P | 2007-09-28 | US | |
| 90555 P | 2008-08-20 | US |
| (72) |
ZHANG, Xiaokui, US
VOSKINARIAN-BERSE, Vanessa A., US
KANG, Lin, US
PADLIYA, Neerav Dilip, US
HARIRI, Robert, US
HEIDARAN, Mohammad A., US
PAL, Ajai, US
ZEITLIN, Andrew, US
|
| (73) |
Celularity Inc.,
33 Technology Drive, Warren, NJ 07059,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Naviko supresija, naudojant placentos perfuzatą ir iš žmogaus placentos gautas tarpines natūralias ląsteles-žudikes |
| TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS |
| Payment date | Validity (years) | Amount | |
| 2023-08-31 | 16 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-09-29 |